Technology sets a new benchmark for real-time CDMO transparency
Shilpa Biologicals Pvt. Ltd. (SBPL)* today announced the launch of Partner PowerTM, a purpose-built digital transparency platform that empowers global sponsors with uninterrupted, real-time insights into every stage of their biologics development and manufacturing programs.
Engineered as a unified digital ‘data fabric,’ PartnerPowerTM replaces traditional periodic reporting with a continuously live, collaborative environment, enabling biopharmaceutical innovators worldwide to monitor the true ‘state of affairs’ of their projects at any moment, from anywhere in the world. It delivers real-time visibility into process development laboratories and GMP manufacturing environments, providing sponsors with direct access to operational data as it is generated. By linking information across R&D, analytical development and manufacturing operations, the platform is designed to support closer coordination, faster decision-making and more efficient technology transfer.
The launch is another component of Shilpa Biologicals’ wider strategy to elevate the global CDMO experience from transactional outsourcing to a fully integrated, partnership-driven model.
The platform has also been designed with data integrity and sponsor confidentiality as core principles, and aligned with the expectations of global regulatory authorities – including the US FDA, EMA, and PMDA- it enables a continuous state of audit readiness.
Madhav Bhutada, Director, Shilpa Biologicals, commented: “With PartnerPowerTM, we are setting a new global benchmark for what transparency in a CDMO partnership should look like. It allows our sponsors to innovate with complete confidence, knowing that every data point, every decision, and milestone is visible to them in real time.”
The launch of PartnerPowerTM adds to Shilpa Biologicals’ continued investment in world-class biologics capabilities, including its dedicated bioconjugation suites for Antibody-Drug Conjugates (ADCs), one of the world’s largest microbial sites as well as a commercial mAbs facility. You can meet the team at booth no 3351 at BIO San Diego’26.
